Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-Elicited SARS-CoV-2 Immune Responses

Journal:

Journal of Infectious Diseases

Published:

2026-02-17

DOI:

10.1093/infdis/jiag091

Affiliations:

18

Authors:

26

Go to article

Institutions	Authors	Share
La Jolla Institute for Immunology (LJI), United States of America (USA)	6.000000	0.23
University of California, San Diego (UC San Diego), United States of America (USA)	3.000000	0.12
Harvard University, United States of America (USA)	2.000000	0.08
Brigham and Women's Hospital (BWH), United States of America (USA)	2.000000	0.08
University of Pittsburgh (Pitt), United States of America (USA)	2.000000	0.08
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	1.000000	0.04
Rush University Medical Center, United States of America (USA)	1.000000	0.04
Moderna, United States of America (USA)	1.000000	0.04
DLH, United States of America (USA)	1.000000	0.04
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	1.000000	0.04
Fred Hutchinson Cancer Center, United States of America (USA)	1.000000	0.04
Lundquist Institute for Biomedical Innovation, United States of America (USA)	1.000000	0.04
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	1.000000	0.04
UCLA Health, United States of America (USA)	1.000000	0.04
University of Washington (UW), United States of America (USA)	0.500000	0.02
UW Medical Center (UWMC), United States of America (USA)	0.500000	0.02
Case Western Reserve University (CWRU), United States of America (USA)	0.500000	0.02
University Hospitals Cleveland Medical Center, CWRU, United States of America (USA)	0.500000	0.02

Interested in Immunology?